Atlas Bio

Raised $12.5M, announced 27 October 2026.

Round

Atlas Bio raised $12.5 million to use AI simulations for running drug trials.

Amount
$12.5M
Announced
27 October 2026
Lead
Creandum
Use of funds
Grow its scientific and commercial teams, improve its platform, and take on more enterprise customers through 2026.
Total raised
$12.5M to date
Checked
Amount and date checked against the press source

Company

Uses artificial intelligence simulations to conduct and accelerate drug trials

Based in
Basel
Founded
2024
Sector
AI
Website
atlasbio.tech ↗

Founders

  • Simon Romanskifounder
  • Sebastian Bayerco-founder & CTO

Sources and links

Source
Ex-Google, self-driving engineers’ Atlas Bio raises $12.5M run drug trials as AI simulations techfundingnews.com
Website
atlasbio.tech ↗
MediaBoost

Just raised?

MediaBoost gets your round in front of the press, future hires and your next investors.

Announce your round with MediaBoost